Ningetinib in Advanced NSCLC Skipping Mutations With MET Exon 14 Skipping Mutations
Clinical trial NCT04992858 · WITHDRAWN
Trial details
- NCT number
- NCT04992858
- Sponsor
- Sunshine Lake Pharma Co., Ltd.
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-27
- Primary completion
- 2024-09-09
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.